ID: ALA2430757

Max Phase: Preclinical

Molecular Formula: C20H23FN4O

Molecular Weight: 354.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCNC(=O)Cn1nc(-c2cccc(F)c2)c2ccccc21

Standard InChI:  InChI=1S/C20H23FN4O/c1-24(2)12-6-11-22-19(26)14-25-18-10-4-3-9-17(18)20(23-25)15-7-5-8-16(21)13-15/h3-5,7-10,13H,6,11-12,14H2,1-2H3,(H,22,26)

Standard InChI Key:  XIFLODDZTOJMOK-UHFFFAOYSA-N

Associated Targets(non-human)

Trypanosoma brucei 78846 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.43Molecular Weight (Monoisotopic): 354.1856AlogP: 2.91#Rotatable Bonds: 7
Polar Surface Area: 50.16Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.30CX LogP: 2.57CX LogD: 0.68
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: -1.98

References

1. Gilbert IH..  (2013)  Drug discovery for neglected diseases: molecular target-based and phenotypic approaches.,  56  (20): [PMID:24015767] [10.1021/jm400362b]

Source